CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sienna Cancer Diagnostics Ltd Company Snapshot
Sienna Cancer Diagnostics Ltd operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sienna Cancer Diagnostics Ltd with three other pharmaceutical manufacturers in Australasia: Anatara Lifesciences Ltd (2018 sales of 1.56 million Australian Dollars [US$1.13 million] ), Bod Australia Ltd (893,828.00 Australian Dollars [US$646,765.00 ] ), and Orthocell Ltd (902,682.00 Australian Dollars [US$653,171.67 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sienna Cancer Diagnostics Ltd
  Stock Performance Chart for Sienna Cancer Diagnostics Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): .08
(Figures in Australian Dollars)
1 Week n/a   13 Weeks 2.4%  
4 Weeks -10.6%   52 Weeks -29.5%  
 
Sienna Cancer Diagnostics Ltd Key Data:
  Ticker: SDX Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 1,295,227
(Year Ending Jan 2019).
Employees: N/A
  Currency: Australian Dollars Market Cap: 15,893,813
  Fiscal Yr Ends: June Shares Outstanding: 189,212,058
  Share Type: STAMMAKTIE Closely Held Shares: 99,146,387
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.